Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.31
-0.43 (-2.73%)
At close: Mar 9, 2026, 4:00 PM EDT
15.48
+0.17 (1.11%)
After-hours: Mar 9, 2026, 7:54 PM EDT

Cullinan Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
904709436483674-
Upgrade
Market Cap Growth
69.76%62.69%-9.73%-28.36%--
Upgrade
Enterprise Value
578134-25-88355-
Upgrade
Last Close Price
15.7412.1810.1910.5515.43-
Upgrade
PE Ratio
---4.34--
Upgrade
PS Ratio
----35.58-
Upgrade
PB Ratio
2.061.200.960.901.59-
Upgrade
P/TBV Ratio
2.011.200.960.901.59-
Upgrade
EV/Sales Ratio
----18.75-
Upgrade
Debt / Equity Ratio
0.000.000.010.01--
Upgrade
Net Debt / Equity Ratio
-0.73-0.67-1.02-0.86-0.68-1.05
Upgrade
Net Debt / EBITDA Ratio
1.372.022.443.504.283.49
Upgrade
Net Debt / FCF Ratio
1.902.733.453.626.697.06
Upgrade
Asset Turnover
----0.06-
Upgrade
Quick Ratio
10.1513.2316.6020.7724.7314.68
Upgrade
Current Ratio
10.4513.5317.0721.0925.2514.82
Upgrade
Return on Equity (ROE)
-40.18%-32.10%-31.37%22.74%-21.57%-39.88%
Upgrade
Return on Assets (ROA)
-26.53%-22.26%-22.80%-16.55%-13.03%-23.93%
Upgrade
Return on Invested Capital (ROIC)
-138.70%-214.14%-601.95%-89.53%-108.71%-
Upgrade
Return on Capital Employed (ROCE)
-53.50%-33.30%-41.80%-24.50%-16.00%-30.10%
Upgrade
Earnings Yield
-23.85%-23.60%-35.13%23.03%-9.73%-
Upgrade
FCF Yield
-19.17%-20.49%-30.85%-26.46%-6.44%-
Upgrade
Buyback Yield / Dilution
-18.23%-29.41%10.91%-8.27%-116.61%-2088.17%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.